Bicalutamide 150 mg

DRUG3 trials

Sponsors

Sun Yat-sen University, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, CHU de Quebec-Universite Laval

Conditions

Coronavirus InfectionCovid19Metastatic Triple Negative Breast CancerMetastatic Urothelial CarcinomaSARS-CoV Infection

Phase 1

Camostat With Bicalutamide for COVID-19

TerminatedNCT04652765

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsCoronavirus Infection, Covid19, SARS-CoV Infection

Start: 2021-02-03End: 2021-09-15Updated: 2023-10-06

Phase 2

A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer.

WithdrawnNCT06018116

CHU de Quebec-Universite LavalMetastatic Urothelial Carcinoma

Start: 2023-11-07End: 2024-02-12Updated: 2024-02-15

Phase 3

Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer

TerminatedNCT03055312

Sun Yat-sen UniversityMetastatic Triple Negative Breast Cancer

Start: 2016-12-20End: 2020-11-15Updated: 2021-01-28